3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
20
Neoplasms
17
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Carcinoma, Hepatocellular
4
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Neoplasm Metastasis
3
Kidney Neoplasms
3
Carcinoma, Renal Cell
3
Uveal Melanoma
2
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lymphoma
2
Lung Diseases
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.